Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
204.4 EUR | -1.83% | +0.69% | -14.66% |
May. 08 | Certain Shares of Sartorius Stedim Biotech S.A. are subject to a Lock-Up Agreement Ending on 8-MAY-2024. | CI |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Evolution of the average Target Price on Sartorius Stedim Biotech
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sartorius Stedim Biotech
UBS | |
alphavalue | Virendra Chauhan |
BARCLAYS | Charles Pitman |
JEFFERIES | James Vane-Tempest |
CREDIT SUISSE | Dominic Lunn |
JPMORGAN | Richard Vosser |
HSBC | Rajesh Kumar |
BERENBERG | Odysseas Manesiotis |
EPS Revisions
- Stock Market
- Equities
- DIM Stock
- Consensus Sartorius Stedim Biotech